Digital therapeutics

A new class of therapies known as "Digital Therapeutics" is predicting and transforming measurable outcomes for the future of medical care. It is reshaping the structure and management of treatments for a complete set of chronic diseases that adhere to medical interventions driven by software and delivered by medical devices, service, and medication, while collecting, analyzing, and applying real-world evidence and product performance data. Digital Therapeutics, a subset of digital health, is evidence-based therapeutic interventions driven by high-quality software systems that prevent, manage, and treat a medical disorder or disease. Digital Therapeutics often employs strategies rooted in cognitive behavioral therapy. Digital Therapeutics harness technology to supplement or potentially replace traditional clinical therapy. Various devices complement traditional treatment by helping patients manage their condition. From my experience, Digital Therapeutics tend to fall into a variety of groups, Cognitive-Behavior Therapies (CBT) that help patients change behaviors and develop coping strategies around their condition, target lifestyle issues and or a combination with existing medication or treatments, helping patients manage their therapies and focus on ensuring the therapy delivers the best outcomes possible. One of the areas that I find most interesting is that Digital Therapeutics will augment drugs by wrap-around services and data analytics to improve overall patient outcomes. I have found that Digital Therapeutics value is to target conditions that are poorly addressed by the healthcare system of today, such as chronic diseases or neurological disorders. In addition, the delivery of Therapeutic Treatments reduces the demands on clinicians' time. The treatments frequently require a prescription and can target prevention or management of a range of conditions, often chronic diseases, while collecting emerging real-world evidence that demonstrate their value in clinical terms. Today's remote advanced technologies have provided many opportunities for healthcare organizations to enhance the overall care experience, improve the health of...
Jessica Shull will be a speaker at the MedTech Forum on 16/5. Find more about the programme here ! Due to the makeup of our household, I am privy to the daily activities of a gang of fourteen-year-old girls. They are all, to a one, surgically attached to their mobile phones. I've learned from them that they trust their mobile phones more than they trusts books in a library or what the high school teachers tell them. When they want to determine if a rash is contagious, or want to know why they have white spots on their nails, they go straight to their phones. This is not to say a mobile-centric world is recommended. It simply provides a glimpse of a trend we face as this generation gets older and takes responsibility for their healthcare. I live in Spain where the wait time to see an orthopaedic surgeon for severe back pain can be 90 days. A patient asking to see a psychologist for stress and depression will also have to choose between an appointment in three months, or a few hastily prescribed pills now. There is over-saturation and lack of professional staff. Spain is not the only country in Europe in this position. It is quite easy to imagine, therefore, where today's fourteen-year-olds will be looking for treatment by the time they are adults. Digital therapeutics (DTx) are digital health products that are driven by high-quality software programs and deliver evidence-based therapeutic interventions to patients to prevent, manage, or treat a medical disorder or disease. These digital health products are used independently or in concert with medications or devices, to optimize health outcomes. These are not wellness or fitness apps. DTx are clinically validated and often prescribed by a physician. A few weeks ago, I was speaking with...